The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; 9 of the 14 sources its claims cite were checked for support.
The WHO estimates of excess mortality associated with the COVID-19 pandemic
Open accessPublished version of a preprint
Abstract
. Reported statistics on COVID-19 mortality are problematic for many countries owing to variations in testing access, differential diagnostic capacity and inconsistent certification of COVID-19 as cause of death. Beyond what is directly attributable to it, the pandemic has caused extensive collateral damage that has led to losses of lives and livelihoods. Here we report a comprehensive and consistent measurement of the impact of the COVID-19 pandemic by estimating excess deaths, by month, for 2020 and 2021. We predict the pandemic period all-cause deaths in locations lacking complete reported data using an overdispersed Poisson count framework that applies Bayesian inference techniques to quantify uncertainty. We estimate 14.83 million excess deaths globally, 2.74 times more deaths than the 5.42 million reported as due to COVID-19 for the period. There are wide variations in the excess death estimates across the six World Health Organization regions. We describe the data and methods used to generate these estimates and highlight the need for better reporting where gaps persist. We discuss various summary measures, and the hazards of ranking countries' epidemic responses.
Overview
CoChat Summary
TL;DR
WHO estimated global excess mortality from COVID-19 for January 2020–December 2021 at 14.83 million deaths, using a Bayesian Poisson framework to fill gaps where all-cause mortality data were incomplete. The estimate is 2.74 times the 5.42 million COVID-19 deaths reported to WHO for the same period.
Key findings
- Globally, the paper estimates 14.83 million excess deaths over 2020–2021 (95% UI 13.23–16.58 million), compared with 5.42 million reported COVID-19 deaths; the excess-to-reported ratio is 2.74 (UI 2.44–3.06).
- Excess deaths were estimated at 4.47 million in 2020 and 10.36 million in 2021 globally; the global P-score increased from 7.97% in 2020 to 18.30% in 2021.
- The paper reports large country-level totals, including India: 4.74 million excess deaths (UI 3.31–6.45 million), Russian Federation: 1.07 million (UI 1.05–1.10 million), Indonesia: 1.03 million (UI 0.75–1.29 million), and the United States: 932,000 (UI 887,000–978,000).
- The 20 countries with the highest excess estimates account for 48.9% of the global population and over 80% of estimated global excess deaths for January 2020–December 2021.
Methods
- The study used a WHO-led, consultative modelling process: a Technical Advisory Group developed methods, WHO member states reviewed preliminary estimates, and feedback was used to update the final estimates.
- The analysis used all-cause mortality (ACM) data from multiple sources; monthly national data were available for 100 countries (52%), while other locations had annual, subnational, or no data.
- Excess deaths were estimated with a Bayesian Poisson / negative binomial framework: historical ACM (often 2015–2019) was used to model expected deaths with spline-based seasonal and annual trends; where pandemic data were incomplete, a covariate-based log-linear model and, for some countries, subnational-to-national multinomial/proportionality models were used.
Limitations
- The paper states that the biggest limitation is data paucity: for almost half of WHO member states, ACM data during the pandemic were unavailable, so estimates relied on statistical models; the text says these countries should be interpreted with caution.
- The paper states that the counterfactual trend is sensitive to modelling assumptions, including the choice of spline models and how recent historical years are weighted; it notes splines can produce inappropriate extrapolations.
- The text makes evident that comparisons across countries/regions are difficult because countries differ in age structure, data completeness, and reporting quality; this is stated in the paper and means rankings can be misleading.
- The text makes evident that the paper cannot quantify how much excess mortality is directly COVID-19 versus indirect or non-COVID causes; the discussion explicitly says excess mortality combines these and cannot separate them.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
8 Valid · 2 Not valid · 6 Not checked · 81 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Reported statistics on COVID-19 mortality are problematic for many countries owing to variations in testing access, differential diagnostic capacity and inconsistent certification of COVID-19 as cause of death.”
- Also stated in: § Main · plain
“countries have differed in their application of standards for the certification of COVID-19 as the underlying cause-of-death2.”
§ The WHO estimates of excess mortality associated with the COVID-19 pandemic > Abstract
What the sources say
- Supportedcites [2] Riffe, T. & Acosta, E. Data Resource Profile: COVerAGE-DB: a global demographic database of COVID-19 cases and deaths. Int. J. Epidemiol. 50, 390–390f (2021). source
The Strengths and weaknesses section says COVID-19 death counts are likely underestimated for reasons also affecting case counts, including testing capacity and diagnostic-test accuracy. It also describes differences in whether suspected deaths are counted and evidence that COVID-19-related deaths are classified under other causes. Page numbers were not supplied in our copy. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Main · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“The measure overcomes the variation among countries in reporting and testing and the misclassification of the cause of death on death certificates7”
§ The WHO estimates of excess mortality associated with the COVID-19 pandemic > Main
What the sources say
- Supportedcites [7] Beaney, T. et al. Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? J. Royal Soc. Med. 113, 329–334 (2020). source
The Excess mortality section states that, because it encompasses deaths from all causes, excess mortality overcomes cross-country variation in COVID-19 reporting and testing and misclassification of causes on death certificates. This directly matches the attributed claim. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This surpasses the influenza pandemics of 1957, 1968 and 2009 (estimated at 0.04%, 0.03% and 0.005%, respectively)18.”
§ The WHO estimates of excess mortality associated with the COVID-19 pandemic > Discussion
What the sources say
- Supportedcites [18] Simonsen, L. & Viboud, C. Mortality: a comprehensive look at the COVID-19 pandemic death toll. eLife 10, e71974 (2021). source
Table 1 (Abstract) gives a global per capita excess mortality rate of >0.08% for COVID-19, exceeding its estimates of 0.04%, 0.03%, and 0.005% for the 1957, 1968, and 2009 influenza pandemics, respectively. The paper describes the COVID-19 estimate using data available in 2020–2021. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As another example, in the Africa region for which ACM data are most lacking, recent studies have highlighted the underestimation in the reported statistics20.”
§ The WHO estimates of excess mortality associated with the COVID-19 pandemic > Discussion
What the sources say
- Supportedcites [20] Cabore J. W. et al. COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns. Lancet Glob. Health 10, e1099–e1114 (2022). source
The Introduction states that reported infections and deaths underestimate the actual COVID-19 burden in the WHO African region. It also reports that, in countries with seroprevalence studies, reported infections represented only a small proportion of the estimated burden. Page numbers were not provided. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The uncertainty in the expected predictions is well modelled by a gamma distribution, and the advantage of this choice is that it can be conveniently combined with a Poisson model to produce a negative binomial model with the log-linear mean given by equation (3).”
§ The WHO estimates of excess mortality associated with the COVID-19 pandemic > Methods > Model for countries without full pandemic data For almost half of the 194 WHO member states we do not have the ACM counts over the pandemic, and so must predict them using country characteristics. We choose a simple form for this prediction model, with mean2where is a relative rate parameter. If , then for country and at month the mortality is greater than expected, whereas if , then for country and at month the mortality is less than expected. We used time-invariant variables, (these are annual values from 2019). These were an indicator of high income and/or low or middle income, the cardiovascular mortality rate in 2019 and the diabetes prevalence rate in 2019. In addition, we used time-varying variables: a containment variable (it is calculated using all ordinal containment and closure policy indicators and health-system policy indicators, for further details see Hale et al.14), the square root of the reported COVID-19 death rate, temperature and the COVID-19 test positivity rate. We then build a log-linear model for the rate parameter:3where and denote relative rate parameters and are independent error contributions that pick up random variation unexplained by the log-linear regression function. The time-varying coefficients allow the associations to evolve during the pandemic. As we desire the evolution to be smooth in time, for these time-varying coefficients we use a random walk of order 2 (RW2) prior that encourages smooth estimates46. In equation (2) above, we have conditioned on known expected numbers. In reality, and as just described, these are modelled to give a distribution over plausible values. The uncertainty in the expected predictions is well modelled by a gamma distribution, and the advantage of this choice is that it can be conveniently combined with a Poisson model to produce a negative binomial model with the log-linear mean given by equation (3). Full details (including evidence of the accuracy of the gamma model) can be found in Knutson et al.15. This model was fitted to all countries with observed monthly ACM data over some portion of 2020–2021, using the integrated nested Laplace approximation method47, to obtain posterior distributions over the unknown parameters. The resultant posterior distribution reflects the uncertainty in the parameters (both in the expected numbers and the log-linear covariate model), and can be used to construct a predictive distribution for the ACM in countries with no data or partial data.
What the sources say
- Supportedcites Knutson et al.15 Knutson V., Aleshin-Guendel S., Karlinsky A., Msemburi W. & Wakefield J. Estimating country-specific excess mortality during the COVID-19 pandemic (2023). Ann. Appl. Stat. (in the press). source
Section 3.3 (Modeling Uncertainty in the Expected Numbers) states they fit a gamma distribution by method of moments to the Monte Carlo samples of the expected numbers and 'approximate the distribution of the expected numbers as gamma, since this is conjugate to the Poisson, and so allows efficient inference with INLA ... using a negative binomial,' and the Supplementary Materials (Sec. 5, Gamma Expected Numbers; Fig. 5) report the gamma fits are accurate, with differences 'small in all cases' — supporting 'well modelled'. The model description bullet confirms the negative binomial component with known tau arises from the uncertainty in the expected numbers within the log-linear Poisson/negative-binomial formulation. The 'equation (3)' reference is the citing paper's own display, not attributed content. (LLM, conf=0.90)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
49 more claims
Create a free account to see all 97 claims and every source verdict.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 30
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our current estimate of global excess mortality during 2020 and 2021 is comparable to the WHO estimate of 14·9 million (95% UI 13·3–16·6) excess deaths,15 with our mean estimate falling within the uncertainty interval of the WHO estimate and vice versa.”
From Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“this total greatly exceeds global average increases of 8% in 2020 and 18% in 20214.”
From Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city (2023) · cites this paper as [4]
In the citing paper
“Other settings with >25% increases in mortality during the pandemic have included Russia and LMICs within Latin America, Eastern Europe, and central Asia1,4.”
From Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city (2023) · cites this paper as [4]
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Generalized Additive Models: An Introduction with R
Wood, S. N. (2017) · doi:10.1201/9781315370279 · Cited by 13,852
Rue, H., Martino, S., & Chopin, N. (2009) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2008.00700.x · Cited by 5,279
Rue, H., & Held, L. (2005) · Chapman & Hall/CRC eBooks · doi:10.1201/9780203492024 · Cited by 1,823
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798
Karlinsky, A., & Kobak, D. (2021) · eLife · doi:10.7554/elife.69336 · Cited by 772
Self-citationMurray, C. J., Lopez, A. D., Chin, B., Feehan, D., & Hill, K. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69895-4 · Cited by 605
Islam, N., Shkolnikov, V. M., Acosta, R. J., Klimkin, I., Kawachi, I., Irizarry, R. A., Alicandro, G., Khunti, K., Yates, T., Jdanov, D. A., et al. (2021) · BMJ · doi:10.1136/bmj.n1137 · Cited by 468
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002056 · Cited by 424
Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?
Beaney, T., Clarke, J. M., Jain, V., Golestaneh, A. K., Lyons, G., Salman, D., & Majeed, A. (2020) · Journal of the Royal Society of Medicine · doi:10.1177/0141076820956802 · Cited by 370
Research works printed but not linked: 2
- National Bureau of Statistics of China. China Statistical Yearbook 2021 (China Statistics Press, 2021).
- Hale, T. et al. Variation in Government Responses to COVID-19 Technical Report (Univ. Oxford, 2020).
Cited by
Schumacher, A. E., Kyu, H. H., Aali, A., Abbafati, C., Abbas, J., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., Abd ElHafeez, S., Abdelmasseh, M., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00476-8 · Cited by 1,045
Health and related indicators 2021
Ndlovu, N., Day, C., Gray, A., Busang, J., & Mureithi, L. (2022) · South African Health Review · doi:10.61473/001c.75480 · Cited by 253
Scoping review: longitudinal effects of the COVID-19 pandemic on child and adolescent mental health
Wolf, K., & Schmitz, J. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02206-8 · Cited by 242
Delving into LLM-assisted writing in biomedical publications through excess vocabulary
Kobak, D., González-Márquez, R., Horvát, E.-Á., & Lause, J. (2024) · arXiv · doi:10.48550/arxiv.2406.07016 · Cited by 214
COVID-19 and its long-term sequelae: what do we know in 2023?
Lippi, G., Sanchis‑Gomar, F., & Henry, B. M. (2023) · Polish Archives of Internal Medicine · doi:10.20452/pamw.16402 · Cited by 190
Metadata
- Authors
- Msemburi, W., Karlinsky, A., Knutson, V., Aleshin-Guendel, S., Chatterji, S., & Wakefield, J.
- Affiliations
- World Health Organization (CH)
- Hebrew University of Jerusalem (IL)
- University of Washington (US)
- Corresponding author
- Msemburi, William
- Venue
- Nature
- Published
- 2022-12-14
- Volume
- 613
- Issue
- 7942
- Pages
- 130-137
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC9812776
- OpenAlex
- W4311472757
- Cited by
- 1,064
- References
- 17
- Citations by year
- 2026: 176 · 2025: 283 · 2024: 346 · 2023: 252 · 2022: 6
- FWCI
- 131.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Epidemiology › Data-Driven Disease Surveillance
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- COVID-19 pandemic, excess mortality, all-cause mortality, underreporting of deaths, cause of death certification, Bayesian uncertainty quantification, WHO regions
- MeSH terms
- COVID-19, Bayes Theorem, Humans, World Health Organization, Poisson Distribution, Uncertainty, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The WHO estimates of excess mortality associated with the COVID-19 pandemic. https://app.cochat.ai/papers/10.1038/s41586-022-05522-2
- The paper
- Msemburi, W., Karlinsky, A., Knutson, V., Aleshin-Guendel, S., Chatterji, S., & Wakefield, J. (2023). The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. https://doi.org/10.1038/s41586-022-05522-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.